Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CCR1 | P32246 | 2/20 | 0.37 |
| ▸ | CCR5 | P51681 | 2/20 | 0.37 |
| ▸ | CCR8 | P51685 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | ALPL | P05186 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16658479 | 0.96 | GRM5 (0.43) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL16658502 | 0.93 | GRM5 (0.41) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL2733743 | 0.92 | GRM5 (0.41) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL17014604 | 0.86 | CCR1 (0.42) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL17014605 | 0.86 | CCR1 (0.42) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL18058474 | 0.84 | KDR (0.39) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL2734770 | 0.83 | SMN1; SMN2 (0.46) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL3892684 | 0.83 | TGFBR1 (0.44) | GRM5SMN1; SMN2LMNANPC1RAB9A | |
| SCHEMBL16859291 | 0.83 | ALDH1A1 (0.44) | SMN1; SMN2RAB9AHPGDKDM4EALDH1A1 | |
| SCHEMBL2158220 | 0.83 | ALDH1A1 (0.47) | SMN1; SMN2RAB9AHPGDKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10026901-B2 | Organic electronic material and organic electroluminescent device | GUANGDONG AGLAIA OPTOELECTRONICS MATERIALS CO., LTD (CN) | 2018-07-17 | — | — | US | disclosed |
| US-10026901-B2 | Organic electronic material and organic electroluminescent device | GUANGDONG AGLAIA OPTOELECTRONICS MATERIALS CO., LTD (CN) | 2018-07-17 | — | — | US | disclosed |
| US-20150108449-A1 | ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2015-04-23 | — | — | US | disclosed |
| US-20150108449-A1 | ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150108449-A1 | ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | OCIAD1, OCIAD2, SLCO4C1 | GRM5 4369/4885SMN1; SMN2 2655/4885LMNA 3270/4885 |
| US-10026901-B2 | Organic electronic material and organic electroluminescent device | OCIAD1, OCIAD2, SLCO4C1 | GRM5 4369/4885SMN1; SMN2 2655/4885LMNA 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.